{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T10:26:09Z","timestamp":1783506369045,"version":"3.55.0"},"reference-count":119,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcardioanesthesia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1053\/j.jvca.2025.05.040","type":"journal-article","created":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T18:38:59Z","timestamp":1748111939000},"page":"2446-2459","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Anticoagulation Monitoring During Extracorporeal Membrane Oxygenation: A Narrative Review"],"prefix":"10.1053","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6193-3662","authenticated-orcid":false,"given":"Sasa","family":"Rajsic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4901-8861","authenticated-orcid":false,"given":"Christian","family":"Irsara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Griesmacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Brunelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Breitkopf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Innerhofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Eckhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedikt","family":"Treml","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1053\/j.jvca.2025.05.040_bib0001","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s13613-016-0196-7","article-title":"Predictive factors of bleeding events in adults undergoing extracorporeal membrane oxygenation","volume":"6","author":"Aubron","year":"2016","journal-title":"Ann Intensive Care"},{"issue":"5","key":"10.1053\/j.jvca.2025.05.040_bib0002","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.3390\/jcm11051224","article-title":"ECMO predictors of mortality: A 10-year referral centre experience","volume":"11","author":"Treml","year":"2022","journal-title":"J Clin Med"},{"issue":"8","key":"10.1053\/j.jvca.2025.05.040_bib0003","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1007\/s00134-022-06723-z","article-title":"How to manage anticoagulation during extracorporeal membrane oxygenation","volume":"48","author":"Levy","year":"2022","journal-title":"Intensive Care Med"},{"issue":"7","key":"10.1053\/j.jvca.2025.05.040_bib0004","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1161\/hq0701.093686","article-title":"Mechanism of action and pharmacology of unfractionated heparin","volume":"21","author":"Hirsh","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"10.1053\/j.jvca.2025.05.040_bib0005","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/MAT.0000000000001652","article-title":"2021 ELSO Adult and Pediatric Anticoagulation Guidelines","volume":"68","author":"McMichael","year":"2022","journal-title":"ASAIO J"},{"issue":"2","key":"10.1053\/j.jvca.2025.05.040_bib0006","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.jtha.2022.11.014","volume":"21","author":"Helms","year":"2023","journal-title":"J Thromb Haemost"},{"issue":"1","key":"10.1053\/j.jvca.2025.05.040_bib0007","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1186\/s13054-016-1570-4","article-title":"The inflammatory response to extracorporeal membrane oxygenation (ECMO): A review of the pathophysiology","volume":"20","author":"Millar","year":"2016","journal-title":"Crit Care"},{"issue":"4","key":"10.1053\/j.jvca.2025.05.040_bib0008","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1365-2141.2005.05753.x","article-title":"The interactions between inflammation and coagulation","volume":"131","author":"Esmon","year":"2005","journal-title":"Br J Haematol"},{"issue":"9","key":"10.1053\/j.jvca.2025.05.040_bib0009","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1056\/NEJMra2104091","article-title":"Heparin resistance - Clinical perspectives and management strategies","volume":"385","author":"Levy","year":"2021","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1053\/j.jvca.2025.05.040_bib0010","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1124\/pr.115.011247","article-title":"Pharmacology of heparin and related drugs","volume":"68","author":"Mulloy","year":"2016","journal-title":"Pharmacol Rev"},{"issue":"3","key":"10.1053\/j.jvca.2025.05.040_bib0011","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.1365-2141.2011.08990.x","article-title":"False prolongation of the activated partial thromboplastin time (aPTT) in inflammatory patients: Interference of C-reactive protein","volume":"157","author":"van Rossum","year":"2012","journal-title":"Br J Haematol"},{"issue":"9","key":"10.1053\/j.jvca.2025.05.040_bib0012","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1053\/j.jvca.2024.04.006","article-title":"Impact of C-reactive protein on anticoagulation monitoring in extracorporeal membrane oxygenation","volume":"38","author":"Madhok","year":"2024","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"9","key":"10.1053\/j.jvca.2025.05.040_bib0013","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.3390\/jcm11092314","article-title":"The role of excessive anticoagulation and missing hyperinflammation in ECMO-associated bleeding","volume":"11","author":"Rajsic","year":"2022","journal-title":"J Clin Med"},{"issue":"2","key":"10.1053\/j.jvca.2025.05.040_bib0014","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1097\/PCC.0b013e31827127e4","article-title":"Variability in anticoagulation management of patients on extracorporeal membrane oxygenation: An international survey","volume":"14","author":"Bembea","year":"2013","journal-title":"Pediatr Crit Care Med"},{"issue":"3","key":"10.1053\/j.jvca.2025.05.040_bib0015","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/ALN.0000000000003044","article-title":"Anticoagulation management and antithrombin supplementation practice during veno-venous extracorporeal membrane oxygenation: A worldwide survey","volume":"132","author":"Protti","year":"2020","journal-title":"Anesthesiology"},{"key":"10.1053\/j.jvca.2025.05.040_bib0016","unstructured":"Extracorporeal Life Support Organization (ELSO). Registry report on extracorporeal life support, international summary. 2024. Available at: https:\/\/www.elso.org\/Registry\/InternationalSummaryandReports\/InternationalSummary.aspx. Accessed July 8, 2024."},{"issue":"1","key":"10.1053\/j.jvca.2025.05.040_bib0017","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1527-3466.2002.tb00081.x","article-title":"Fondaparinux, a synthetic pentasaccharide: The first in a new class of antithrombotic agents - The selective factor Xa inhibitors","volume":"20","author":"Bauer","year":"2002","journal-title":"Cardiovasc Drug Rev"},{"issue":"5","key":"10.1053\/j.jvca.2025.05.040_bib0018","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1124\/dmd.108.025569","article-title":"Metabolism and excretion of rivaroxaban, an oral, direct factor Xa inhibitor, in rats, dogs, and humans","volume":"37","author":"Weinz","year":"2009","journal-title":"Drug Metab Dispos"},{"issue":"5","key":"10.1053\/j.jvca.2025.05.040_bib0019","doi-asserted-by":"crossref","first-page":"R102","DOI":"10.1186\/cc6119","article-title":"Pharmacokinetics and pharmacodynamics of danaparoid during continuous venovenous hemofiltration: A pilot study","volume":"11","author":"de Pont","year":"2007","journal-title":"Crit Care"},{"issue":"3-4","key":"10.1053\/j.jvca.2025.05.040_bib0020","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/0049-3848(79)90159-2","article-title":"Molecular weight dependency of the heparin potentiated inhibition of thrombin and activated factor X. Effect of heparin neutralization in plasma","volume":"15","author":"Andersson","year":"1979","journal-title":"Thromb Res"},{"key":"10.1053\/j.jvca.2025.05.040_bib0021","series-title":"Extracorporeal life support: The Red Book 5th edition","year":"2017"},{"issue":"6","key":"10.1053\/j.jvca.2025.05.040_bib0022","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1097\/MAT.0000000000000273","article-title":"Anticoagulation for extracorporeal life support: Direct thrombin inhibitors and heparin","volume":"61","author":"Coughlin","year":"2015","journal-title":"ASAIO J"},{"issue":"1","key":"10.1053\/j.jvca.2025.05.040_bib0023","doi-asserted-by":"crossref","first-page":"64S","DOI":"10.1378\/chest.119.1_suppl.64S","article-title":"Heparin and low-molecular-weight heparin: Mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety","volume":"119","author":"Hirsh","year":"2001","journal-title":"Chest"},{"key":"10.1053\/j.jvca.2025.05.040_bib0024","series-title":"Hemostasis and thrombosis: Basic principles and clinical practice","first-page":"837","article-title":"The heparin-antithrombin system: A natural anticoagulant mechanism","author":"Rosenberg","year":"1994"},{"issue":"2","key":"10.1053\/j.jvca.2025.05.040_bib0025","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1172\/JCI114723","article-title":"Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors","volume":"86","author":"Weitz","year":"1990","journal-title":"J Clin Invest"},{"issue":"17","key":"10.1053\/j.jvca.2025.05.040_bib0026","doi-asserted-by":"crossref","first-page":"5147","DOI":"10.3390\/jcm11175147","article-title":"Anticoagulation strategies during extracorporeal membrane oxygenation: A narrative review","volume":"11","author":"Rajsic","year":"2022","journal-title":"J Clin Med"},{"issue":"2","key":"10.1053\/j.jvca.2025.05.040_bib0027","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1152\/ajplegacy.1916.41.2.250","article-title":"The thromboplastic action of cephalin","volume":"41","author":"McLean","year":"1916","journal-title":"Am J Physiol"},{"issue":"1","key":"10.1053\/j.jvca.2025.05.040_bib0028","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1161\/01.CIR.19.1.75","article-title":"The discovery of heparin","volume":"19","author":"McLean","year":"1959","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2025.05.040_bib0029","first-page":"5","article-title":"Production and chemical processing of low molecular weight heparins","author":"Linhardt","year":"1999","journal-title":"Semin Thromb Hemost"},{"issue":"3","key":"10.1053\/j.jvca.2025.05.040_bib0030","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0025-7125(16)30155-9","article-title":"Low-molecular-weight heparin","volume":"78","author":"Wolf","year":"1994","journal-title":"Med Clin North Am"},{"issue":"4 Suppl","key":"10.1053\/j.jvca.2025.05.040_bib0031","article-title":"Heparin: Mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety","volume":"108","author":"Hirsh","year":"1995","journal-title":"Chest"},{"key":"10.1053\/j.jvca.2025.05.040_bib0032","doi-asserted-by":"crossref","unstructured":"Berk ZBK, Shah A, Sun W, et al. An ex vivo comparison of partial thromboplastin time and activated clotting time for heparin anticoagulation in an ovine model. 2022;46(3):501-5. doi:https:\/\/doi.org\/10.1111\/aor.14094","DOI":"10.1111\/aor.14094"},{"issue":"04","key":"10.1053\/j.jvca.2025.05.040_bib0033","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1055\/s-0037-1599153","article-title":"Point-of-care coagulation testing in cardiac surgery","volume":"43","author":"Bolliger","year":"2017","journal-title":"Semin Thromb Hemost"},{"issue":"12","key":"10.1053\/j.jvca.2025.05.040_bib0034","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1053\/j.jvca.2024.09.003","article-title":"Association of Activated Clotting Time-Guided Anticoagulation with Complications during Extracorporeal Membrane Oxygenation Support: A Systematic Review and Meta-Analysis","volume":"38","author":"Schwaiger","year":"2024","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"11","key":"10.1053\/j.jvca.2025.05.040_bib0035","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1053\/j.jvca.2024.07.048","article-title":"Anticoagulation monitoring using activated clotting time in patients receiving extracorporeal membrane oxygenation: A meta-analysis of correlation coefficients","volume":"38","author":"Rajsic","year":"2024","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"1","key":"10.1053\/j.jvca.2025.05.040_bib0036","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13054-020-2726-9","article-title":"Clinical controversies in anticoagulation monitoring and antithrombin supplementation for ECMO","volume":"24","author":"Chlebowski","year":"2020","journal-title":"Crit Care"},{"issue":"12)","key":"10.1053\/j.jvca.2025.05.040_bib0037","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.3390\/diagnostics11122202","article-title":"Diagnostic modalities in critical care: Point-of-care approach","volume":"11","author":"Rajsic","year":"2021","journal-title":"Diagnostics Basel"},{"issue":"1","key":"10.1053\/j.jvca.2025.05.040_bib0038","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1182\/bloodadvances.2020003265","article-title":"ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease","volume":"5","author":"James","year":"2021","journal-title":"Blood Adv"},{"issue":"1","key":"10.1053\/j.jvca.2025.05.040_bib0039","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/ajcp\/aqac013","article-title":"An analysis of the sensitivity of the activated partial thromboplastin time (APTT) assay, as used in a large laboratory network, to coagulation factor deficiencies","volume":"158","author":"Do","year":"2022","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"10.1053\/j.jvca.2025.05.040_bib0040","doi-asserted-by":"crossref","DOI":"10.11613\/BM.2021.020708","article-title":"Reporting of activated partial thromboplastin time (aPTT): Could we achieve better comparability of the results?","volume":"31","author":"Broni\u0107","year":"2021","journal-title":"Biochem Med"},{"issue":"6","key":"10.1053\/j.jvca.2025.05.040_bib0041","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/ijlh.12109","article-title":"Determination of APTT factor sensitivity\u2013the misguiding guideline","volume":"35","author":"Lawrie","year":"2013","journal-title":"Int J Lab Hematol"},{"issue":"3","key":"10.1053\/j.jvca.2025.05.040_bib0042","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1007\/s11239-019-01879-w","article-title":"Influence of factor XII deficiency on activated partial thromboplastin time (aPTT) in critically ill patients","volume":"48","author":"Bachler","year":"2019","journal-title":"J Thromb Thrombolysis"},{"key":"10.1053\/j.jvca.2025.05.040_bib0043","first-page":"39","article-title":"Factor XII (Hageman Factor) deficiency: A rare harbinger of life threatening complications","volume":"33","author":"Chaudhry","year":"2019","journal-title":"Pan Afri Med J"},{"issue":"5","key":"10.1053\/j.jvca.2025.05.040_bib0044","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.thromres.2011.11.016","article-title":"Monitoring unfractionated heparin with APTT: A French collaborative study comparing sensitivity to heparin of 15 APTT reagents","volume":"129","author":"Gouin-Thibaut","year":"2012","journal-title":"Thromb Res"},{"issue":"5","key":"10.1053\/j.jvca.2025.05.040_bib0045","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/vox.12514","article-title":"Adult extracorporeal membrane oxygenation: An international survey of transfusion and anticoagulation techniques","volume":"112","author":"Esper","year":"2017","journal-title":"Vox Sang"},{"key":"10.1053\/j.jvca.2025.05.040_bib0046","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcrc.2023.154332","article-title":"aPTT-guided anticoagulation monitoring during ECMO support: A systematic review and meta-analysis","volume":"77","author":"Rajsic","year":"2023","journal-title":"J Crit Care"},{"issue":"9","key":"10.1053\/j.jvca.2025.05.040_bib0047","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.3390\/jcm12093224","article-title":"Association of aPTT-guided anticoagulation monitoring with thromboembolic events in patients receiving V-A ECMO support: A systematic review and meta-analysis","volume":"12","author":"Rajsic","year":"2023","journal-title":"J Clin Med"},{"issue":"12","key":"10.1053\/j.jvca.2025.05.040_bib0048","doi-asserted-by":"crossref","DOI":"10.1002\/clc.70061","article-title":"Anticoagulation monitoring during ECMO support: Monitor or flip a coin?","volume":"47","author":"Rajsic","year":"2024","journal-title":"Clin Cardiol"},{"key":"10.1053\/j.jvca.2025.05.040_bib0049","doi-asserted-by":"crossref","unstructured":"Reisinger AC, Schneider N, Koellinger M, et al. Anticoagulation monitoring strategies during extracorporeal membrane oxygenation (ECMO) therapy \u2013 differences between simultaneously obtained coagulation tests: A retrospective single-center cohort study. J Intensive Care Med 2025;40(6):651-9. doi:10.1177\/08850666241313357","DOI":"10.1177\/08850666241313357"},{"issue":"11","key":"10.1053\/j.jvca.2025.05.040_bib0050","first-page":"e0999","volume":"5","author":"Aubron","year":"2023","journal-title":"Crit Care Explor"},{"issue":"8","key":"10.1053\/j.jvca.2025.05.040_bib0051","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1177\/02676591221129741","article-title":"Discordance among assays for monitoring? Anticoagulation during extracorporeal life support","volume":"38","author":"Scott","year":"2023","journal-title":"Perfusion"},{"key":"10.1053\/j.jvca.2025.05.040_bib0052","doi-asserted-by":"crossref","unstructured":"Delmas C, Jacquemin A, Vardon-Bounes F, et al. Anticoagulation monitoring under ECMO support: A comparative study between the activated coagulation time and the anti-Xa activity assay. 2020;35(7):679-86. doi:10.1177\/0885066618776937","DOI":"10.1177\/0885066618776937"},{"issue":"1","key":"10.1053\/j.jvca.2025.05.040_bib0053","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s13054-021-03554-0","article-title":"Anti-Xa activity and hemorrhagic events under extracorporeal membrane oxygenation (ECMO): A multicenter cohort study","volume":"25","author":"Descamps","year":"2021","journal-title":"Crit Care"},{"issue":"12","key":"10.1053\/j.jvca.2025.05.040_bib0054","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1055\/s-0043-1770096","article-title":"Factors influencing anti-Xa assays: A multicenter prospective study in critically ill and noncritically ill patients receiving unfractionated heparin","volume":"123","author":"Lasne","year":"2023","journal-title":"Thromb Haemost"},{"issue":"6","key":"10.1053\/j.jvca.2025.05.040_bib0055","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/j.0954-6820.1967.tb07991.x","article-title":"Heparin-resistance in amyloidosis","volume":"181","author":"Christiansen","year":"1967","journal-title":"Acta Med Scand"},{"issue":"1","key":"10.1053\/j.jvca.2025.05.040_bib0056","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/s12871-023-02147-4","article-title":"Heparin-resistance in AL amyloidosis: A case report","volume":"23","author":"van Ede","year":"2023","journal-title":"BMC Anesthesiol"},{"key":"10.1053\/j.jvca.2025.05.040_bib0057","unstructured":"Extracorporeal Life Support Organization (ELSO). ELSO Anticoagulation guideline. 2014. Available at: https:\/\/www.elso.org\/ecmo-resources\/elso-ecmo-guidelines.aspx. Accessed 10.02.2025."},{"issue":"4","key":"10.1053\/j.jvca.2025.05.040_bib0058","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1055\/s-0039-1697950","article-title":"Anti-factor Xa-based anticoagulation during extracorporeal membrane oxygenation: Potential problems and possible solutions","volume":"46","author":"Ranucci","year":"2020","journal-title":"Semin Thromb Hemost"},{"key":"10.1053\/j.jvca.2025.05.040_bib0059","unstructured":"European Medicines Agency. Ondexxya: Commercial anti-FXa activity assays are unsuitable for measuring anti-FXa activity following administration of andexanet alfa. 2024. Available at:https:\/\/www.ema.europa.eu\/en\/documents\/dhpc\/direct-healthcare-professional-communication-dhpc-ondexxya-andexanet-alfa-commercial-anti-fxa-activity-assays-are-unsuitable-measuring-anti-fxa-activity-following-administration-andexanet-alfa_en.pdf. Accessed November 26, 2024."},{"issue":"6","key":"10.1053\/j.jvca.2025.05.040_bib0060","article-title":"Andexanet alfa for edoxaban reversal and associated thromboelastography changes in surgical pulmonary embolectomy","volume":"16","author":"Fukuda","year":"2024","journal-title":"Cureus"},{"issue":"1","key":"10.1053\/j.jvca.2025.05.040_bib0061","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1053\/j.jvca.2020.08.017","article-title":"Intraoperative off-label reversal of apixaban by andexanet alfa while on VA-ECMO immediately after emergent surgery for acute type A aortic dissection","volume":"35","author":"Kainz","year":"2021","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2025.05.040_bib0062","doi-asserted-by":"crossref","unstructured":"Willems A, Roeleveld PP, Labarinas S, et al. Anti-Xa versus time-guided anticoagulation strategies in extracorporeal membrane oxygenation: A systematic review and meta-analysis. 2021;36(5):501-12. doi:10.1177\/0267659120952982","DOI":"10.1177\/0267659120952982"},{"issue":"5","key":"10.1053\/j.jvca.2025.05.040_bib0063","doi-asserted-by":"crossref","DOI":"10.1002\/clc.24273","article-title":"Association of anti-factor Xa-guided anticoagulation with hemorrhage during ECMO support: A systematic review and meta-analysis","volume":"47","author":"Rajsic","year":"2024","journal-title":"Clin Cardiol"},{"issue":"8","key":"10.1053\/j.jvca.2025.05.040_bib0064","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1053\/j.jvca.2024.03.042","article-title":"Anti-Xa-guided anticoagulation with unfractionated heparin and thrombosis during extracorporeal membrane oxygenation support: A systematic review and meta-analysis","volume":"38","author":"Rajsic","year":"2024","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2025.05.040_bib0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.talo.2021.100059","article-title":"In vivo real-time monitoring of anti-factor Xa level using a microdialysis-coupled microfluidic device","volume":"4","author":"Zhou","year":"2021","journal-title":"Talanta Open"},{"issue":"21","key":"10.1053\/j.jvca.2025.05.040_bib0066","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1182\/blood-2016-11-709873","article-title":"Heparin-induced thrombocytopenia","volume":"129","author":"Arepally","year":"2017","journal-title":"Blood"},{"issue":"1","key":"10.1053\/j.jvca.2025.05.040_bib0067","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s13054-021-03581-x","article-title":"Argatroban versus heparin in patients without heparin-induced thrombocytopenia during venovenous extracorporeal membrane oxygenation: A propensity-score matched study","volume":"25","author":"Fisser","year":"2021","journal-title":"Crit Care"},{"issue":"4","key":"10.1053\/j.jvca.2025.05.040_bib0068","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1177\/0885066621993739","article-title":"Argatroban anticoagulation for adult extracorporeal membrane oxygenation: A systematic review","volume":"37","author":"Geli","year":"2022","journal-title":"J Intensive Care Med"},{"issue":"1","key":"10.1053\/j.jvca.2025.05.040_bib0069","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/ejh.13520","article-title":"Anticoagulation strategies in extracorporeal circulatory devices in adult populations","volume":"106","author":"Kato","year":"2021","journal-title":"Eur J Haematol"},{"issue":"2","key":"10.1053\/j.jvca.2025.05.040_bib0070","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1177\/08971900221143406","article-title":"Meta-analysis comparing bivalirudin versus unfractionated heparin in adult patients with extracorporeal membrane oxygenation","volume":"37","author":"Kido","year":"2024","journal-title":"J Pharm Pract"},{"key":"10.1053\/j.jvca.2025.05.040_bib0071","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.thromres.2021.12.024","article-title":"Is bivalirudin an alternative anticoagulant for extracorporeal membrane oxygenation (ECMO) patients? A systematic review and meta-analysis","volume":"210","author":"Li","year":"2022","journal-title":"Thromb Res"},{"key":"10.1053\/j.jvca.2025.05.040_bib0072","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106089","article-title":"Bivalirudin versus heparin in adult and pediatric patients with extracorporeal membrane oxygenation therapy: A systematic review and meta-analysis","volume":"177","author":"Liu","year":"2022","journal-title":"Pharmacol Res"},{"issue":"4","key":"10.1053\/j.jvca.2025.05.040_bib0073","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s40256-020-00450-w","article-title":"A review of bivalirudin for pediatric and adult mechanical circulatory support","volume":"21","author":"Taylor","year":"2021","journal-title":"Am J Cardiovasc Drugs"},{"issue":"2","key":"10.1053\/j.jvca.2025.05.040_bib0074","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/MAT.0000000000001808","article-title":"Heparin versus bivalirudin for anticoagulation in adult extracorporeal membrane oxygenation: A systematic review and meta-analysis","volume":"69","author":"Wieruszewski","year":"2023","journal-title":"ASAIO J"},{"issue":"6","key":"10.1053\/j.jvca.2025.05.040_bib0075","doi-asserted-by":"crossref","first-page":"R275","DOI":"10.1186\/cc10556","article-title":"Bivalirudin-based versus conventional heparin anticoagulation for postcardiotomy extracorporeal membrane oxygenation","volume":"15","author":"Ranucci","year":"2011","journal-title":"Crit Care"},{"issue":"9","key":"10.1053\/j.jvca.2025.05.040_bib0076","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1097\/CCM.0000000000005033","article-title":"Comparison of bivalirudin versus heparin for maintenance systemic anticoagulation during adult and pediatric extracorporeal membrane oxygenation","volume":"49","author":"Seelhammer","year":"2021","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1053\/j.jvca.2025.05.040_bib0077","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12959-022-00401-2","article-title":"Evaluation of clinical outcomes in patients treated with heparin or direct thrombin inhibitors during extracorporeal membrane oxygenation: A systematic review and meta-analysis","volume":"20","author":"M\u2019Pembele","year":"2022","journal-title":"Thromb J"},{"issue":"8","key":"10.1053\/j.jvca.2025.05.040_bib0078","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/MAT.0000000000002172","article-title":"Unresponsiveness of activated partial thromboplastin time to bivalirudin in adults receiving extracorporeal membrane oxygenation","volume":"70","author":"Jatis","year":"2024","journal-title":"ASAIO J"},{"key":"10.1053\/j.jvca.2025.05.040_bib0079","series-title":"Contemporary practice in clinical chemistry","first-page":"445","article-title":"Chapter 26 - Hemostasis","author":"Campbell","year":"2020"},{"key":"10.1053\/j.jvca.2025.05.040_bib0080","doi-asserted-by":"crossref","DOI":"10.1111\/jth.12149","article-title":"Measuring oral direct inhibitors (ODIs) of thrombin and factor Xa: A recommendation from the Subcommittee on Control of Anticoagulation of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis","author":"Baglin","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1053\/j.jvca.2025.05.040_bib0081","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/978-1-62703-339-8_20","article-title":"Reptilase time (RT)","volume":"992","author":"Karapetian","year":"2013","journal-title":"Methods Mol Biol"},{"key":"10.1053\/j.jvca.2025.05.040_bib0082","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1177\/0004563215599795","article-title":"Diluted thrombin time reliably measures low to intermediate plasma dabigatran concentrations","volume":"53","author":"Bo\u017ei\u010d-Mijovski","year":"2016","journal-title":"Ann Clin Biochem"},{"key":"10.1053\/j.jvca.2025.05.040_bib0083","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.thromres.2024.02.026","article-title":"Anticoagulation with argatroban using hemoclot\u2122 targets is safe and effective in CARDS patients receiving venovenous extracorporeal membrane oxygenation: An exploratory bi-centric cohort study","volume":"236","author":"Mayerh\u00f6fer","year":"2024","journal-title":"Thromb Res"},{"issue":"3","key":"10.1053\/j.jvca.2025.05.040_bib0084","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/ijlh.13780","article-title":"How to best monitor bivalirudin anticoagulant effect for ECMO and VAD-Comparison of four assay methods","volume":"44","author":"Teruya","year":"2022","journal-title":"Int J Lab Hematol"},{"issue":"3","key":"10.1053\/j.jvca.2025.05.040_bib0085","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.transci.2016.05.016","article-title":"An update on laboratory measurements of dabigatran: Smart specific and calibrated dedicated assays for measuring anti-IIa activity in plasma","volume":"54","author":"Amiral","year":"2016","journal-title":"Transfus Apher Sci"},{"issue":"12","key":"10.1053\/j.jvca.2025.05.040_bib0086","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1160\/TH17-04-0280","article-title":"Diagnostic accuracy of a novel chromogenic direct thrombin inhibitor assay: Clinical experiences for dabigatran monitoring","volume":"117","author":"Poli","year":"2017","journal-title":"Thromb Haemost"},{"issue":"4","key":"10.1053\/j.jvca.2025.05.040_bib0087","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000081505","article-title":"The ecarin clotting time, a universal method to quantify direct thrombin inhibitors","volume":"33","author":"Nowak","year":"2003","journal-title":"Pathophysiol Haemost Thromb"},{"issue":"4","key":"10.1053\/j.jvca.2025.05.040_bib0088","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1159\/000081506","article-title":"Ecarin chromogenic assay\u2013a new method for quantitative determination of direct thrombin inhibitors like hirudin","volume":"33","author":"Lange","year":"2003","journal-title":"Pathophysiol Haemost Thromb"},{"issue":"2","key":"10.1053\/j.jvca.2025.05.040_bib0089","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/ALN.0000000000004787","article-title":"Monitoring of argatroban in critically ill patients: A prospective study comparing activated partial thromboplastin time, point-of-care viscoelastic testing with ecarin clotting time and diluted thrombin time to mass spectrometry","volume":"140","author":"Heubner","year":"2024","journal-title":"Anesthesiology"},{"key":"10.1053\/j.jvca.2025.05.040_bib0090","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.thromres.2023.05.022","article-title":"Use of ecarin chromogenic assay during bivalirudin anticoagulation in adult extracorporeal membrane oxygenation","volume":"228","author":"Krauter","year":"2023","journal-title":"Thromb Res"},{"key":"10.1053\/j.jvca.2025.05.040_bib0091","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcmd.2020.102526","article-title":"Acquired von Willebrand syndrome in ECMO patients: A 3-year cohort study","volume":"87","author":"Panholzer","year":"2021","journal-title":"Blood Cells Mol Dis"},{"issue":"9","key":"10.1053\/j.jvca.2025.05.040_bib0092","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1016\/j.jtha.2024.06.007","article-title":"Acquired von Willebrand syndrome during extracorporeal membrane oxygenation support: A comprehensive review of current evidence: communication from the ISTH SSC on perioperative and critical care thrombosis and hemostasis","volume":"22","author":"Frere","year":"2024","journal-title":"J Thromb Haemost"},{"issue":"6","key":"10.1053\/j.jvca.2025.05.040_bib0093","first-page":"781","article-title":"Multiple electrode aggregometry: A new device to measure platelet aggregation in whole blood","volume":"96","author":"T\u00f3th","year":"2006","journal-title":"Thromb Haemost"},{"issue":"5","key":"10.1053\/j.jvca.2025.05.040_bib0094","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/aor.14142","article-title":"Extracorporeal membrane oxygenation seems to induce impairment of primary hemostasis pathology as measured by a multiplate analyzer: An observational retrospective study","volume":"46","author":"Garaj","year":"2022","journal-title":"Artif Organs"},{"issue":"1","key":"10.1053\/j.jvca.2025.05.040_bib0095","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1067\/mtc.2001.114344","article-title":"Clinical utility of the platelet function analyzer (PFA-100) in cardiothoracic procedures involving extracorporeal circulation","volume":"122","author":"Raman","year":"2001","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"5","key":"10.1053\/j.jvca.2025.05.040_bib0096","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1055\/s-2006-947869","article-title":"The utility of the PFA-100 in the identification of von Willebrand disease: A concise review","volume":"32","author":"Favaloro","year":"2006","journal-title":"Semin Thromb Hemost"},{"key":"10.1053\/j.jvca.2025.05.040_bib0097","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.thromres.2020.01.029","article-title":"Utility of the platelet function analyser (PFA-100\/200) for exclusion or detection of von Willebrand disease: A study 22 years in the making","volume":"188","author":"Favaloro","year":"2020","journal-title":"Thromb Res"},{"issue":"Suppl 6","key":"10.1053\/j.jvca.2025.05.040_bib0098","article-title":"Basic principles of viscoelastic testing","volume":"60","author":"Carll","year":"2020","journal-title":"Transfusion"},{"issue":"3","key":"10.1053\/j.jvca.2025.05.040_bib0099","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.thromres.2013.01.009","article-title":"Impact of changes in haematocrit level and platelet count on thromboelastometry parameters","volume":"131","author":"Nagler","year":"2013","journal-title":"Thromb Res"},{"issue":"2","key":"10.1053\/j.jvca.2025.05.040_bib0100","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/MAT.0000000000001196","article-title":"Thromboelastometry, thromboelastography, and conventional tests to assess anticoagulation during extracorporeal support: A prospective observational study","volume":"67","author":"Giani","year":"2021","journal-title":"ASAIO J"},{"key":"10.1053\/j.jvca.2025.05.040_bib0101","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcrc.2024.154830","article-title":"Point of care guided coagulation management in adult patients on ECMO: A systematic review and meta-analysis","volume":"83","author":"Saracoglu","year":"2024","journal-title":"J Crit Care"},{"issue":"12","key":"10.1053\/j.jvca.2025.05.040_bib0102","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1111\/jth.15538","article-title":"Clinical use of thrombin generation assays","volume":"19","author":"Binder","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1053\/j.jvca.2025.05.040_bib0103","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.thromres.2022.02.011","article-title":"Coagulation activation during extracorporeal membrane oxygenation (ECMO)","volume":"211","author":"Chandler","year":"2022","journal-title":"Thromb Res"},{"issue":"1","key":"10.1053\/j.jvca.2025.05.040_bib0104","doi-asserted-by":"crossref","first-page":"7975","DOI":"10.1038\/s41598-021-87026-z","article-title":"Hemostasis, coagulation and thrombin in venoarterial and venovenous extracorporeal membrane oxygenation: The HECTIC study","volume":"11","author":"Cartwright","year":"2021","journal-title":"Sci Rep"},{"issue":"12","key":"10.1053\/j.jvca.2025.05.040_bib0105","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1111\/jth.15052","article-title":"Anticoagulant and signaling functions of antithrombin","volume":"18","author":"Rezaie","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"1","key":"10.1053\/j.jvca.2025.05.040_bib0106","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/jth.14648","article-title":"Recommendations for clinical laboratory testing for antithrombin deficiency; Communication from the SSC of the ISTH","volume":"18","author":"Van Cott","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1053\/j.jvca.2025.05.040_bib0107","doi-asserted-by":"crossref","unstructured":"Panigada M, Cucino A, Spinelli E, et al. A randomized controlled trial of antithrombin supplementation during extracorporeal membrane oxygenation. 2020;48(11):1636-44. doi:10.1097\/ccm.0000000000004590","DOI":"10.1097\/CCM.0000000000004590"},{"issue":"6","key":"10.1053\/j.jvca.2025.05.040_bib0108","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1097\/ALN.0000000000004920","article-title":"Antithrombin levels and heparin responsiveness during venoarterial extracorporeal membrane oxygenation: A prospective single-center cohort study","volume":"140","author":"Mansour","year":"2024","journal-title":"Anesthesiology"},{"issue":"6","key":"10.1053\/j.jvca.2025.05.040_bib0109","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1177\/0267659120913803","article-title":"A narrative review of antithrombin use during veno-venous extracorporeal membrane oxygenation in adults: Rationale, current use, effects on anticoagulation, and outcomes","volume":"35","author":"Piacente","year":"2020","journal-title":"Perfusion"},{"issue":"4","key":"10.1053\/j.jvca.2025.05.040_bib0110","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s41669-021-00272-9","article-title":"Hospital costs of extracorporeal membrane oxygenation in adults: A systematic review","volume":"5","author":"Oude Lansink-Hartgring","year":"2021","journal-title":"Pharmacoecon Open"},{"issue":"4","key":"10.1053\/j.jvca.2025.05.040_bib0111","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1177\/0018578719890091","article-title":"Cost-effectiveness of argatroban versus heparin anticoagulation in adult extracorporeal membrane oxygenation patients","volume":"56","author":"Cho","year":"2021","journal-title":"Hosp Pharm"},{"key":"10.1053\/j.jvca.2025.05.040_bib0112","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.flowmeasinst.2016.06.025","article-title":"Cole-Cole analysis of thrombus formation in an extracorporeal blood flow circulation using electrical measurement","volume":"53","author":"Nguyen Huu","year":"2017","journal-title":"Flow Meas Instrum"},{"key":"10.1053\/j.jvca.2025.05.040_bib0113","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.bios.2018.04.020","article-title":"Red blood cells aggregability measurement of coagulating blood in extracorporeal circulation system with multiple-frequency electrical impedance spectroscopy","volume":"112","author":"Li","year":"2018","journal-title":"Biosens Bioelectron"},{"issue":"1","key":"10.1053\/j.jvca.2025.05.040_bib0114","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-59873-z","article-title":"Early thrombus detection in the extracorporeal membrane oxygenation circuit by noninvasive real-time ultrasonic sensors","volume":"14","author":"Rim","year":"2024","journal-title":"Sci Rep"},{"issue":"8","key":"10.1053\/j.jvca.2025.05.040_bib0115","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1177\/0391398820978656","article-title":"Real-time, non-invasive thrombus detection in an extracorporeal circuit using micro-optical thrombus sensors","volume":"44","author":"Morita","year":"2021","journal-title":"Int J Artif Organs"},{"issue":"10","key":"10.1053\/j.jvca.2025.05.040_bib0116","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/aor.12862","article-title":"Optical dynamic analysis of thrombus inside a centrifugal blood pump during extracorporeal mechanical circulatory support in a porcine model","volume":"41","author":"Fujiwara","year":"2017","journal-title":"Artif Organs"},{"key":"10.1053\/j.jvca.2025.05.040_bib0117","doi-asserted-by":"crossref","unstructured":"Sakurai H, Fujiwara T, Ohuchi K, et al. Novel application of indocyanine green fluorescence imaging for real-time detection of thrombus in a membrane oxygenator. 2021;45(10):1173-82. doi:https:\/\/doi.org\/10.1111\/aor.13999","DOI":"10.1111\/aor.13999"},{"issue":"6","key":"10.1053\/j.jvca.2025.05.040_bib0118","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/aor.12782","article-title":"Detection of thrombosis in the extracorporeal membrane oxygenation circuit by infrasound: Proof of concept","volume":"41","author":"Fuchs","year":"2017","journal-title":"Artif Organs"},{"issue":"7","key":"10.1053\/j.jvca.2025.05.040_bib0119","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/aor.12244","article-title":"Acoustic analysis of a mechanical circulatory support","volume":"38","author":"Hubbert","year":"2014","journal-title":"Artif Organs"}],"container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053077025004343?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053077025004343?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T05:46:20Z","timestamp":1754977580000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053077025004343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":119,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S1053077025004343"],"URL":"https:\/\/doi.org\/10.1053\/j.jvca.2025.05.040","relation":{},"ISSN":["1053-0770"],"issn-type":[{"value":"1053-0770","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anticoagulation Monitoring During Extracorporeal Membrane Oxygenation: A Narrative Review","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiothoracic and Vascular Anesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.jvca.2025.05.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}